Picture of Orexo AB logo

ORX Orexo AB Income Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for Orexo AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
R2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSPRESSPRESS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue56562463929.726
Cost of Revenue
Gross Profit4865225501111.5
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses779808748457379
Operating Profit-214-184-110-427-353
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-223-170-140-478-403
Provision for Income Taxes
Net Income After Taxes-224-178-128-478-403
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-224-178-128-203639
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-224-178-128-203639
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.654-1.9-1.45-13.9-11.6
Dividends per Share